May 12, 2020 / 10:09 PM / 14 days ago

BRIEF-aTyr Pharma Announces Q1 EPS Of $0.25

May 12 (Reuters) - aTyr Pharma Inc:

* ATYR PHARMA ANNOUNCES FIRST QUARTER 2020 RESULTS AND PROVIDES CORPORATE UPDATE ON ATYR1923 CLINICAL TRIALS IN PULMONARY SARCOIDOSIS AND COVID-19

* ATYR PHARMA INC - TOTAL REVENUES WERE $8.1 MILLION FOR THREE MONTHS ENDED MARCH 31, 2020, CONSISTING PRIMARILY OF LICENSING REVENUE FROM KYORIN AGREEMENT

* ATYR PHARMA INC - QTRLY EARNINGS PER SHARE $0.25

* ATYR PHARMA INC - AS OF MARCH 31, 2020, ATYR HAD $49.8 MILLION IN CASH, CASH EQUIVALENTS AND INVESTMENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below